Results 191 to 200 of about 11,688 (259)

Response to cabergoline treatment, gonadal axis recovery, and outcomes of drug withdrawal, in men with microprolactinoma: a retrospective cohort study. [PDF]

open access: yesEndocrine
Rudman Y   +9 more
europepmc   +1 more source

Cabergoline and the risk of valvular lesions in endocrine disease.

open access: green, 2008
Patrizio Lancellotti   +7 more
openalex   +1 more source

Rare Occurrence of Distant Metastases in Prolactinoma: Insights From 2 Cases and Review of the Literature. [PDF]

open access: yesAACE Endocrinol Diabetes
Master V   +6 more
europepmc   +1 more source

PDB29 PHARMACOECONOMIC EVALUATION OF CABERGOLINE FOR THE MANAGEMENT OF HYPERPROLACTINEMIA CAUSED BY HYPOPHYSEAL MICROADENOMA IN MEXICO

open access: bronze, 2008
Miguel Ángel Guillén-González   +7 more
openalex   +1 more source

Session 23. Reproductive endocrinology [PDF]

open access: yes, 2017
Bertazzoli, M.   +55 more
core  

Cabergoline-induced prolactinoma treatment and subsequent estrogen-driven vascular smooth muscle tumorigenesis in a middle-aged female: A case report. [PDF]

open access: yesInt J Surg Case Rep
Cintrón-Cartagena K   +5 more
europepmc   +1 more source

Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas [PDF]

open access: bronze, 2013
Renata S. Auriemma   +8 more
openalex   +1 more source

Update on Medical Treatment of Cushing's Syndrome. [PDF]

open access: yesDrugs
Dillon BR   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy